A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic dermatitis
Abstract Objectives In the United Kingdom, atopic dermatitis (AD) affects 20% of children and topical corticosteroids (TCS) are a mainstay of AD treatment regimes. Many TCS have similar packaging despite significant differences in potency frequently leading to confusion, and along with misinformatio...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-03-01
|
| Series: | Skin Health and Disease |
| Online Access: | https://doi.org/10.1002/ski2.11 |